Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EC grants orphan status to pralatrexate for cutaneous T-cell lymphoma

June 21, 2010

Arno Therapeutics doses first patient in phase I/IIa trial of AR-42

June 21, 2010

CanBas and Takeda to terminate collaboration for anticancer agent CBP-501

June 21, 2010

Merck & Co. presents promising clinical data on MK-4827, MK-1775 and MK-0752

June 21, 2010

Interim phase II data presented on vorinostat/gemtuzumab ozogamicin in AML

June 21, 2010

Chugai Pharmaceutical claims novel prodrugs for cancer therapy

June 21, 2010

FDA approves Jevtana for metastatic hormone-refractory prostate cancer

June 18, 2010

Thallion closes phase II TLN-232 trial following arbitral tribunal decision

June 18, 2010

OncoMed and Bayer Schering form anticancer stem cell alliance

June 18, 2010

Phase II trial of GDC-0449 in colorectal cancer does not meet primary endpoint

June 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...